The Translational Research Program was established to encourage and provide support for new and novel clinical research. The goal of the program is to accelerate transfer of findings from the laboratory to clinical application. The program’s purpose is to fund research that shows high promise for translating basic biomedical knowledge to prevention or new treatments and, ultimately, to prolong and enhance life. A renewal of the grant may be funded for an additional two years if it includes an approved clinical trial. A principal intent of the program is to permit the acquisition of sufficient data to apply to an appropriate agency or sponsor for sustained support. Awards will be limited to a maximum of $200,000, which include direct costs and a maximum overhead of $20,000 or 11.1 percent of direct costs per year for three years. Budget requests should be carefully justified and commensurate with the needs of the project. NOTE 2 STEPS OF APPLICATION: A preliminary application and a full application.
Amount: Check funder
Deadline: Check deadline
Funder: Leukemia & Lymphoma Society
Stage of Study: